X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.cnbctv18.com/market/stocks/zydus-lifesciences-gets-usfda-nod-for-tofacitinib-tablets-16226171.htm
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-22-2023-25079.pdf
https://www.indianpharmapost.com/news/zydus-receives-final-approval-from-the-usfda-for-olanzapine-13855
https://health.economictimes.indiatimes.com/news/pharma/zydus-lifesciences-gets-usfda-nod-to-market-generic-drug/98320181
https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-zydus-gabapentin-tablets/98087826
https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-zydus-canagliflozin-and-metformin-hydrochloride-tablets/98089916
https://www.business-standard.com/article/news-cm/zydus-receives-usfda-tentative-approval-for-canagliflozin-tablet-123021501319_1.html
https://www.reuters.com/business/healthcare-pharmaceuticals/indias-zydus-lifesciences-beats-q3-profit-view-strong-india-us-sales-2023-02-03/
https://www.bqprime.com/markets/zydus-lifesciences-arm-gets-usfda-nod-to-sell-depression-treatment-drug
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-us-fda-final-nod-for-febuxostat-tablets-for-treating-high-uric-acid/articleshow/97006879.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Market Place
Share 
